Olema Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Olema Pharmaceuticals Inc
TickerOLMA
CIK #0001750284
CUSIP68062P106
SectorLife Sciences - Pharmaceutical Preparations
Address512 2Nd Street, 4th Floor, San Francisco, CA 94107
Source [EDGAR]
CIK Filing 2011 - 2024
[0001750284] 10-K
[0001750284] 10-Q
[0001750284] 3
[0001750284] 4
[0001750284] 8-K
[0001750284] D
[0001750284] SC 13D
[0001750284] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Paradigm Biocapital Advisors LP Olema Pharmaceuticals Inc [2023-04-10] 6.2
Kynam Capital Management LP Olema Pharmaceuticals Inc [2023-02-10] 5.0
BlackRock Inc Olema Pharmaceuticals Inc [2022-07-08] 3.2
Fairmount Funds Management LLC Olema Pharmaceuticals Inc [2022-02-11] 5.2
Vanguard Group Inc Olema Pharmaceuticals Inc [2022-02-10] 5.33
BlackRock Inc Olema Pharmaceuticals Inc [2022-02-04] 5.7
RA Capital Management LP Olema Pharmaceuticals Inc [2021-02-16] 5.4
Janus Henderson Group PLC Olema Pharmaceuticals Inc [2021-02-12] 0.1
Wellington Management Group LLP Olema Pharmaceuticals Inc [2021-02-04] 5.15
Logos Global Management LP Olema Pharmaceuticals Inc [2020-12-03] 0.3
Cormorant Asset Management LP Olema Pharmaceuticals Inc [2020-11-23] 2.35
Biotechnology Value Fund L P Olema Pharmaceuticals Inc [2020-11-20] 8.5
Form 3/4/5 Filer 2011 - 2024
Olema Pharmaceuticals, Inc.
Harmon Cyrus
Kovacs Shane William Charles
Moriarty John B
Bohen Sean
Zojwalla Naseem
Myles David C.
Horn Kinney
Clark Ian T
Rappaport Andrew
Graham G. Walmsley
Butitta Cynthia M
Horning Sandra
Hrustanovic Gorjan
Larson Yi
Lampert Mark N
Biotechnology Value Trading Fund OS LP
BVF GP Holdings LLC
BVF II GP LLC
Biotechnology Value Fund II LP
BVF Partners OS Ltd.
BVF Inc/IL
BVF Partners L P/IL
BVF I GP LLC
Biotechnology Value Fund L P
Kushner Peter J.
Wellington Biomedical Innovation Master Investors (Cayman) I
Chen Bihua
Cormorant Private Healthcare Fund III LP
Cormorant Global Healthcare Master Fund, LP
Cormorant Asset Management, LP
Cormorant Private Healthcare Fund II, LP
McCormick Frank
Form 13F Holdings
Firm Period DFND Voting Shares
BVF Inc/IL [2023-03-31] DFND 0.0 7,611,503.0
Logos Global Management LP [2023-03-31] SOLE 3,743,875.0 3,743,875.0
Cormorant Asset Management LP [2023-03-31] DFND 3,082,000.0 3,082,000.0
Paradigm Biocapital Advisors LP [2023-03-31] SOLE 2,382,377.0 2,382,377.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 2,085,179.0
Kynam Capital Management LP [2023-03-31] SOLE 2,011,853.0 2,011,853.0
Vivo Capital LLC [2023-03-31] SOLE 1,689,515.0 1,689,515.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,497,615.0
Citadel Advisors LLC [2023-03-31] DFND 1,231,116.0 1,231,116.0
BlackRock Inc. [2023-03-31] SOLE 948,119.0 996,177.0
Sectoral Asset Management Inc [2023-03-31] SOLE 371,917.0 995,909.0
Acadian Asset Management LLC [2023-03-31] DFND 575,900.0 575,900.0
Laurion Capital Management LP [2023-03-31] SOLE 513,972.0 513,972.0
J Goldman & Co LP [2023-03-31] SOLE 447,083.0 447,083.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 420,000.0 420,000.0
Newtyn Management LLC [2023-03-31] SOLE 375,000.0 375,000.0
Geode Capital Management LLC [2023-03-31] DFND 349,946.0 349,946.0
Vontobel Holding Ltd. [2023-03-31] DFND 337,917.0 337,917.0
Renaissance Technologies LLC [2023-03-31] SOLE 257,200.0 257,200.0
Deutsche Bank AG [2023-03-31] DFND 22,040.0 254,718.0
GSA Capital Partners LLP [2023-03-31] SOLE 230,632.0 230,632.0
Jacobs Levy Equity Management Inc [2023-03-31] SOLE 230,568.0 230,568.0
Monaco Asset Management SAM [2023-03-31] SOLE 221,905.0 221,905.0
Two Sigma Advisers LP [2023-03-31] SOLE 186,000.0 205,900.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 191,215.0 192,215.0
Walleye Capital LLC [2023-03-31] SOLE 182,337.0 182,337.0
Two Sigma Investments LP [2023-03-31] SOLE 161,433.0 161,433.0
State Street Corp [2023-03-31] DFND 121,181.0 121,181.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 115,687.0 115,687.0
Morgan Stanley [2023-03-31] DFND 113,740.0 113,890.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com